May 17, 2012 (San Diego, California) — A 1-year randomized study of postmenopausal women who took the new oral selective estrogen-receptor modulator (SERM) ospemifene (Ophena, Shionogi) for ...

Common causes of postmenopausal bleeding include atrophy and fibroids. Learn about risk factors, treatments, and when to consult a doctor.

Light spotting after menopause can be caused by a few different things, including non-cancerous polyps, vaginal dryness, or excess growth of the tissue that lines the uterus. Less common causes range ...

Postmenopausal bleeding (PMB) raises significant concern in women, as it may signal early uterine malignancy. Consequently, all episodes of PMB require thorough investigation. Approximately 60–80% of ...

Any bleeding after menopause is abnormal, and a doctor should always check it. Vaginal atrophy is the most common cause of ...

Normal menstruation starts at menarche around age 12, and lasts until menopause at around 50 years of age. This bleeding is controlled by the hypothalamo-pituitary-ovarian axis and consists of ...

Choice of therapy is based on patient needs and preferences. Some patients find dosing of the cream confusing. Active estrogen cream dosing is specified in milligrams, the dose of base cream is in ...

Expert Rev of Obstet Gynecol. 2013;8(5):457-465. While treatments for vulvovaginal atrophy have often focused on the vagina, it is critical to address care for the vulvar vestibule as well. The ...